Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Arun Sanyal

Newcastle AuthorsTitleYearFull text
Professor Arun Sanyal
Professor Quentin Anstee
A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial2020
Professor Quentin Anstee
Professor Pierre Bedossa
Professor Arun Sanyal
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial2019
Professor Arun Sanyal
Professor Quentin Anstee
Professor Pierre Bedossa
REGENERATE: Design of a pivotal, randomised, phase 3 study evaluating the safety and efficacy of obeticholic acid in patients with fibrosis due to nonalcoholic steatohepatitis2019
Professor Arun Sanyal
Professor Quentin Anstee
Report on the AASLD/EASL joint workshop on clinical trial endpoints in NAFLD2019
Professor Quentin Anstee
Professor Chris Day
Professor Arun Sanyal
Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-20302018
Professor Quentin Anstee
Professor Arun Sanyal
Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum2017
Professor Quentin Anstee
Professor Arun Sanyal
ALT as a non-invasive biomarker of histological response to pharmacotherapy in NASH patients: insights from the elafibranor GOLDEN505 trial2016
Professor Quentin Anstee
Professor Arun Sanyal
Improvement in NASH histological activity highly correlates with fibrosis regression2016
Professor Quentin Anstee
Professor Arun Sanyal
Validation of mir-34a, mir-122 and mir-200a as bio-markers for identification of NASH patients eligible for treatment2016